Advanced Search

 

Study ID Status Title Patient Level Data
RH01333 Completed A Randomized, Cross-Over, Single Dose Pharmacokinetic Study of 4mg Nicotine Lozenges.
RH01361 Completed Effects of two doses of a common cold treatment on cognitive function
RH01379 Completed A Single Centre, Examiner-blind Human Patch Test of Bactroban Disinfectant Liquid on Normal Skin
RH01381 Completed In Situ Study to Confirm the Anti-caries Potential of a 1.1365% w/w Sodium Monofluorophosphate (1500ppm F) Dentifrice
RH01390 Completed A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model
RH01418 Completed A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers
RH01426 Completed A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity
RH01561 Completed Clinical study to evaluate the efficacy of chlorhexidine mouthwashes
RH01589 Completed A Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Film and Nicotine Lozenge
RH01591 Completed A Proof of Concept Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in the Relief of Dentinal Hypersensitivity
RH01619 Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy of Once-Daily Fluticasone Propionate Aqueous Nasal Spray 200mcg for 14 Days on Ocular Symptoms Associated with Seasonal Allergic Rhinitis
RH01685 Completed A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Long Term Relief from Dentinal Hypersensitivity
RH01705 Completed A pharmacokinetic study comparing two nicotine gum formulations in a single dose design
RHS00691 Completed Meta-analysis of the efficacy of ranitidine 75mg and ranitidine 150mg versus placebo on the reduction of severity or prevention of meal-induced heartburn
RIT-I-000 Completed Phase I/II study of radiolabeled monoclonal antibody anti-B1 for the treatment of B-cell lymphomas.
RIT-II-001 Completed Multicenter, phase II dosimetry/validation study of 131 Iodine anti-B1 (murine) radioimmunotherapy for chemotherapy-refractory low-grade B-cell lymphomas and low-grade lymphomas that have transformed to higher grade histologies.
RIT-II-002 Completed A randomized study of Iodine-131 Anti-B1 Antibody versus Anti-B1 Antibody in chemotherapy-relapsed/refractory low-grade or transformed low-grade non-Hodgkin’s Lymphoma (NHL).
RIT-II-003 Completed Phase II trial of Iodine-131 Anti-B1 Antibody for previously untreated, advanced-stage, low-grade non-Hodgkin’s lymphoma
RM2006/00520/00 Completed A phase II multicenter, randomized, double-blind, placebo-controlled, dose-ranging, parallel group study of the safety and efficacy of a new chemical entity when administered orally in combination with ondansetron hydrochloride and dexamethasone for the prevention of chemotherapy-induced nausea ...
RO12003 Completed Efficacy and Safety of Rosiglitazone in the Treatment of Type 2 Diabetes Mellitus
ROF102100 Completed A randomised, double blind, placebo-controlled, parallel group study to investigate the safety and efficacy of controlled-release ropinirole (CR) (1-24 mg) administered once daily for 12 weeks in subjects with fibromyalgia Study Listed on ClinicalStudyDataRequest.com
ROP105323 Completed A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ropinirole Immediate Release Tablets (REQUIP IR) or Ropinirole Prolonged Release Tablets (SK&F-101468) in Advanced Stage Parkinson’s Disease Subjects who are not Adequately Controlled on L-dopa.
ROP105696 Completed A Post-Marketing Surveillance to monitor the safety of RequipTM (Ropinirole hydrochloride) administered in Korean subjects according to the prescribing information
ROP106064 Completed Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease - an Open-Label, Uncontrolled Study -
ROP109087 Completed An open label, repeat dose, dose escalation study conducted in Parkinson's Disease patients to characterize the pharmacokinetics and effect of food on ropinirole prolonged release (PR/CR) 12mg tablets. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.